Fifth Third Wealth Advisors LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Fifth Third Wealth Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLX) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 1,255 shares of the company’s stock, valued at approximately $204,000.

A number of other institutional investors have also modified their holdings of the business. Mizuho Securities USA LLC grew its holdings in shares of Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP boosted its position in Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after purchasing an additional 453,624 shares during the period. International Assets Investment Management LLC grew its stake in Clorox by 424.9% during the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after buying an additional 435,971 shares during the last quarter. Boston Trust Walden Corp increased its position in Clorox by 5,442.5% in the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after buying an additional 268,966 shares during the period. Finally, State Street Corp lifted its stake in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after buying an additional 245,525 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

Shares of NYSE:CLX opened at $160.31 on Friday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $19.84 billion, a PE ratio of 55.86, a P/E/G ratio of 2.90 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The firm has a fifty day moving average price of $164.25 and a 200 day moving average price of $156.38.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company posted $0.49 EPS. The firm’s revenue was up 27.0% on a year-over-year basis. Analysts expect that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CLX. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. JPMorgan Chase & Co. upped their price target on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday. Evercore ISI decreased their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Barclays dropped their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.